The Chi-square analysis exhibited that high IGFBP3 was negatively correlated with tumor stage, extranodal infiltration, LDH levels, and IPI score, which demonstrated IGFBP3 involved in repressing ABC-DLBCL clinicopathological progression. The gene discussed is IGFBP3; the disease is diffuse large B-cell lymphoma.